Header_Profil.jpg

Recruiting Patients – Fast, Fair, High-Quality

emovis is not only known for its high recruiting numbers. It is also recognized for maintaining and/or exceeding the forecasted study participants recruiting prospects. The reason: emovis demonstrates high-level expertise and is open to innovation when recruiting patients and the Executive Management typically estimates the number of recruits in a conservative manner. A rule of fairness at emovis: Up to now, numerous sponsors were surprised and quite happy.

Search our past trials and recruitment numbers

Start Sponsor Client Time period Recruited Trial Identifier
2004 Depression Imerem, Schwarz Pharma 6 months 5
2004 Depression Lilly Deutschland 3 months 50
2004 Restless legs syndrom Boehringer Ingelheim 3 months 49
2004 Diabetic polyneuropathy INC Research, Schwarz BioSciences 4 months 19
2003 Depression Dr. Willmar Schwabe 14 months 58
2003 Alzheimer disease Sanofi-Synthelabo 15 months 15
2003 Depression H. Lundbeck 7 months 21
2003 Restless legs syndrom UCB S.A. 6 weeks 32
2003 Depression Servier Forschung und Pharma-Entwicklung 2 months 24
2003 Alzheimer disease Janssen-Cilag 4 months 5
2003 Smoking cessation Glaxo Smith Kline Research & Development Ltd. 4 days 101
2002 Depression Servier Forschung und Pharma-Entwicklung 3 months 22
2002 Migraine Bayer AG 3 months 10
2002 Migraine Glaxo Smith Kline Research & Development Ltd. 4 months 55
2002 Restless legs syndrom Boehringer Ingelheim 3 months 35
2002 Restless legs syndrom Glaxo Smith Kline Research & Development Ltd. 3 months 16
2002 Restless legs syndrom Glaxo Smith Kline Research & Development Ltd. 2 weeks 9
2002 Schizophrenia Janssen-Cilag 6 months 8
2002 Depression Dr. Willmar Schwabe 10 months 13
2002 Generalized anxiety disorder Orion Pharma 5 months 35
2002 Social phobia Glaxo Smith Kline Research & Development Ltd. 3 months 25
2001 Depression Servier Forschung und Pharma-Entwicklung 3 months 9
2001 Panic disorder Wyeth 12 months 49
2001 Panic disorder Pfizer Pharma 3 months 4
2000 Social phobia Solvay 3 months 23
2000 Depression Boehringer Ingelheim 12 months 60
2017 Sleep disorder from the age of 55 Eisai Inc. 10 Monate 93 EudraCT-2015-004347-39
2017 Irritable bowel syndrome Dr. Willmar Schwabe 9 Monate 23 EudraCT-2014-004702-14
2017 MDD Janssen-Cilag 11 Monate 12 EudraCT-2016-001929-14
2017 Osteoarthritis Astellas 1 Monat 22 EudraCT-2014-004996-22
2017 Vaccination against clostridium difficile Pfizer Pharma 16 months 26 EudraCT-2016-003866-14
2016 Urinary trakt infections Repha 20 Monate 22 EudraCT-2013-004653-25
2017 Allergic Rhinitis ALK-Abelló 1 Monat 8 EudraCT-2017-000971-97
2017 COPD Astra Zeneca, Pearl 1 Monat 18 EudraCT-2016-000154-34
2017 COPD Verona Pharma 3 Monate 16 EudraCT-2016-005205-40
2017 Influenza Medicago 2 months 92
2018 Early stage alzheimer disease Eisai Inc. 9 months 13 EudraCT-2016-003928-23
2018 Sleep disturbances Idorsia 5 Monate 121 EudraCT-2017-004642-20
2018 Influenza Medicago 2 Wochen 52 EudraCT-2018-001894-26
2018 Osteoarthrosis Regeneron 2 Wochen 23 EudraCT-2017-001702-15
2016 Onychomycosis Almirall 4 Monate 59 EudraCT-2015-000561-31
2015 Osteoarthrosis Regeneron 6 monate 48
2015 COPD Novartis 4 Monate 15 EudraCT-2013-003127-11
2014 Diabetes mellitus Hanmi 5 Monate 1 EudraCT-2013-004250-13
2013 Depression Allergan 12 Monate 25 EudraCT- 2012-001950-25
2012 COPD Allergan, Almirall, Astra Zeneca 6 Monate 27 EudraCT-2011-001524-38
2011 COPD Glaxo Smith Kline Research & Development Ltd. 6 Monate 20 EudraCT-2010-021802-39
2011 Depression Astra Zeneca 5 Months 18 EudraCT-2010-019925-33
2008 Generalized anxiety disorder H. Lundbeck 3 Monate 10 EudraCT-2008-001766-90
2008 Depression Takeda 8 Monate 28 EudraCT-2008-001580-11
2008 Diabetes mellitus Lilly Deutschland 4 monate 4 EudraCT -2008-004207-63
2006 Metrorrhagie Bayer AG 6 Monate 11 EudraCT- 2005-004340-32
2006 Parkinson disease Axxonis 2 Monate 1 EudraCT-2006-003732-30
2006 Restless legs syndrom Boehringer Ingelheim 3 Monate 21 EudraCT-2005-006128-13
2003 Diabetes mellitus Glaxo Smith Kline Research & Development Ltd. 8 Monate 5
2009 Alzheimer disease H. Lundbeck 9 Monate 4
2018 Sleep disturbances Janssen Research 4 Months 9 EudraCT-2017-000980-33
2017 Psoriasis Novartis 4 Monate 4 EudraCT-2015-005170-38
2017 Dyslipidämie Esperion Therapeutics 9 Months 4
2012 Alzheimer disease Avraham Pharmaceuticals Ltd. 17 Monate 32 EudraCT-2010-021926-37
2015 Depression Alkermes 5 Monate 14 EudraCT-2014-000380-41
2017 Migraine CoLucid Pharmaceuticals 4 Monate 17 EudraCT-2015-005689-40
2017 Early stage alzheimer disease Biogen 18 months 55
2018 Onychomycosis Moberg Pharma 5 Months 71 EudraCT-2016-001204-39
2018 Premenstrual syndrome Asarina 6 Months 24 EudraCT-2017-000822-37
2018 Uterusmyom Bayer AG 8 Months 8 EudraCT-2016-002855-48
2018 Migraine Merck Sharp & Dohme Corp. 2 Months 55
2018 Depression Janssen Research, Shire Development LLC 3 Months 29 EudraCT-2015-005282-22
2015 Depression Janssen Research 37 months 24 EudraCT-2015-005282-23
2018 Sleep disturbances Idorsia 1 Month 1 EudraCT-2017-004644-38
2018 Depression Janssen Research 3 Months 40 EudraCT- 2017-002633-28
2019 Depression Janssen Research 3 Months 32 EudraCT-2015-005282-23
2007 Stress Urinary Incontinence Lilly Deutschland 3 Months 6
2009 Contraception Bayer AG 12 Months 60 EudraCT-2009-010599-45
2009 Contraception Bayer AG 12 Months 148 EudraCT-2009-009177-10
2004 Restless legs syndrom Imerem, Schwarz BioSciences 6 Monate 20 EudraCT-2005-000428-18
2004 Alzheimer disease Glaxo Smith Kline Research & Development Ltd. 8 Monate 2 EudraCT-2004-000985-12
2004 Depression Wyeth 3 Monate 27 EudraCT-2004-000562-13
2004 Depression Glaxo Smith Kline Research & Development Ltd. 8 Monate 31
2004 Irritable bowel syndrome Glaxo Smith Kline Research & Development Ltd. 5 Monate 49 EudraCT-2004-000848-24
2004 Social phobia Glaxo Smith Kline Research & Development Ltd. 5 Monate 35 EudraCT-2004-000848-24
2004 Generalized anxiety disorder Lilly Deutschland 10 Monate 14
2005 Depression Glaxo Smith Kline Research & Development Ltd. 2 Monate 1 EudraCT-2004-003803-19
2005 Irritable bowel syndrome Yamanouchi Pharma 2 Monate 12 EudraCT-2004-003880-61
2005 Generalized anxiety disorder Lilly Deutschland 8 Monate 17 EudraCT-2004-002626-22
2005 Depression Boehringer Ingelheim 7 Monate 9
2005 Premenstrual syndrome Wyeth 8 Monate 3 EudraCT-2004-005173-27
2005 Bronchitis Bionorica 2 Wochen 3 EudraCT-2005-003249-15
2005 Panic disorder Elbion 1 Monat 12 EudraCT-2005-005708-17
2006 Restless legs syndrom Imerem 2 Monate 12
2006 Depression Glaxo Smith Kline Research & Development Ltd. 3 Monate 21 EudraCT-2006-001877-13
2006 Depression Servier Forschung und Pharma-Entwicklung 3 Monate 46 EudraCT-2004-004009-10
2006 Depression Sanofi-Aventis 4 Monate 42 EudraCT - 2004-002327-41
2006 Restless legs syndrom Imerem, Schwarz Pharma 2 Monate 11 EudraCT-2004-001589-42
2006 Sleep disturbances Sanofi-Aventis 18 Monate 31 EudraCT- 2005-003082-16
2006 Restless legs syndrom Axxonis 10 Monate 26 EudraCT-2004-001589-42
2006 Generalized anxiety disorder Astra Zeneca 9 Monate 7 EudraCT- 2005-005055-18
2006 Depression Astra Zeneca 4 Monate 13 EudraCT- 2005-003745-14
2006 Irritable bowel syndrome Glaxo Smith Kline Research & Development Ltd. 3 Monate 28
2006 Restless legs syndrom Glaxo Smith Kline Research & Development Ltd. 4 Monate 3
2006 Restless legs syndrom Boehringer Ingelheim 7 Monate 21 EudraCT-2005-005225-54
2006 Hypertension Astra Zeneca 6 Monate 50 EudraCT -2005-005718-19
2006 Social phobia Glaxo Smith Kline Research & Development Ltd. 5 Monate 16 EudraCT- 2006-003597-10
2007 Depression Pierre Fabre 5 Monate 11 EudraCT-2006-002404-34
2007 Generalized anxiety disorder Sanofi-Aventis 6 Monate 16 EudraCT 2006-002253-71
2007 Migraine MSD 5 Monate 35 EudraCT-2006-006187-35
2007 Restless legs syndrom Boehringer Ingelheim 4 Monate 34 EudraCT-2006-006431-42
2007 Hypertension DaiichiSankyo Deutschland 19 Monate 19 EudraCT-2008-008260-28
2007 Postherpetic neuralgia Grünenthal 4 Monate 8
2007 Diabetic polyneuropathy Grünenthal 4 Monate 8 EudraCT-2006-003132-29
2007 Parkinson disease Imerem 3 Monate 1
2007 Diabetic polyneuropathy Swedish Orphan 2 Monate 1 EudraCT- 2006-004007-19
2007 Sleep disturbances Sanofi-Aventis 12 Monate 14 EudraCT-2006-006677-25
2007 Depression Servier Forschung und Pharma-Entwicklung 10 Monate 16 EudraCT-2006-004716-48
2007 Depression Sanofi-Aventis 10 Monate 36 EudraCT-2004-002328-16
2007 Depression Glaxo Smith Kline Research & Development Ltd. 10 Monate 36 EudraCT-2005-003400-11
2007 Sexual dysfunction Boehringer Ingelheim 11 Monate 60 EudraCT-2007-000032-68
2008 Hypertension Takeda 2 Monate 10 EudraCT-2007-002583-10
2008 Lipometabolism disorder MSD 2 Monate 33 EudraCT 2011-001007-12
2008 Sexual dysfunction Bayer AG 4 Monate 13 Eudract-2006-004397-27
2008 Depression H. Lundbeck 6 Monate 30 EudraCT-2008-001580-11
2008 Diabetes mellitus MSD 1 Monat 4 EudraCT-2007-000145-35
2008 Depression Sanofi-Aventis 6 Monate 29 EudraCT-2004-002328-16
2008 Back pain Lilly Deutschland 6 Monate 12 EudraCT-2006-003484-31
2008 Migraine MSD 3 Monate 55 EudraCT-2006-004257-14
2008 Overactive bladder Pfizer Pharma 4 Monate 18 EudraCT-2004-000476-13
2008 Irritable bowel syndrome Menarini 3 Monate 24 EudraCT-2008-000214-71
2008 Vaccination Glaxo Smith Kline Research & Development Ltd. 1 Monat 44
2008 Alzheimer disease IFE Europe 1 Monat 3 EudraCT-2008-002758-39
2008 Generalized anxiety disorder Takeda 2 Monate 7 EudraCT-2008-001766-90
2008 Hypertension Novartis 4 Monate 17 EudraCT- 2006-006068-44
2008 Vaccination MSD 8 Monate 844 EudraCT-2007-004020-20
2009 Diabetes mellitus Lilly Deutschland 2 Monate 4 EudraCT-2009-009889-13
2009 Sleep disturbances Glaxo Smith Kline Research & Development Ltd. 2 Monate 29 EudraCT-2008-006345-72
2009 Depression Takeda 1 Monat 49 EudraCT-2008-001581-91
2009 Alcohol dependency Pierrell Research 15 Monate 28 EudraCT-2007-002315-92
2009 Osteoarthrosis Lilly Deutschland 4 Monate 12 EudraCT-2009-010008-27
2009 Diabetes mellitus Boehringer Ingelheim 8 Monate 2 EudraCT-2008-008296-33
2009 Restless legs syndrom Pfizer Pharma 6 Monate 16 EudraCT-2008-005889-32
2009 Diabetes mellitus Novartis 7 Monate 6 EudraCT-2008-002758-39
2009 Alzheimer disease Servier Forschung und Pharma-Entwicklung 7 Monate 7
2009 Depression H. Lundbeck 2 Monate 6 EudraCT-2007-001871-13
2009 Alzheimer disease H. Lundbeck 7 Monate 10
2009 Birth control Bayer AG 8 Monate 148 EudraCT-2009-009177-10
2009 Alcohol dependency H. Lundbeck 10 Monate 121 EudraCT-2007-002315-92
2010 Depression Glaxo Smith Kline Research & Development Ltd. 4 Monate 22 EudraCT- 2009-010339-42
2010 Alzheimer disease Lilly Deutschland 9 Monate 4 EudraCT-2008-002758-39
2010 Depression Sanofi-Aventis 7 Monate 33 EudraCT-2009-010339-42
2010 Alzheimer disease JSW Lifescience 6 Monate 4
2010 Obstipation in men Shire-Movetis 32 Monate 16 EudraCT-2009-015719-42
2010 Migraine Symbicort, Merck Sharp & Dohme Corp. 1 Monat 27 EudraCT-2010-019288-13
2010 Depression Analyze & Realize, Leiber 5 Monate 95
2010 Vaccination Sanofi-Pasteuer MSD 2 Monate 108 EudraCT-2010-021068-13
2010 Vaccination Glaxo Smith Kline Research & Development Ltd. 2 Monate 40
2010 Erkältungsprophylaxe Analyze & Realize, Leiber 1 Monat 60
2011 Diabetes mellitus Boehringer Ingelheim 15 Monate 18 EudraCT-2010-021375-92
2011 Stress management Dr. Willmar Schwabe 4 Monate 50 EudraCT- 2010-022114-12
2011 Depression Astra Zeneca 5 Monate 18 EudraCT-2010-019925-33
2011 ADHD in adults Novartis 4 Monate 70 EudraCT-2011-004668-31
2011 Hypertension Servier Forschung und Pharma-Entwicklung 6 Monate 25 EudraCT- 2010-020945-28
2011 Chronic obstructive pulmonary disease Glaxo Smith Kline Research & Development Ltd. 9 Monate 21 EudraCT-2010-021802-39
2011 Depression Takeda 5 Monate 46 EudraCT- 2011-005298-22
2011 Diabetes mellitus MetaCure Germany 10 Monate 3 EudraCT- 2010-020945-28
2011 Neurasthenia WELEDA AG 9 Monate 201 EudraCT- 2010-024189-23
2011 Venous insufficiency OM Pharma (Vifor Pharma) 4 Monate 9 EudraCT-2009-013391-44
2011 Restless legs syndrom UCB S.A. 4 Monate 47 EudraCT- 2011-000053-23
2011 Alzheimer disease Genetech 4 Monate 6 EudraCT-2010-021926-37
2011 ADHD in children Shire 7 Monate 10 EudraCT-2010-018579-12
2011 Alzheimer disease Avraham Pharmaceuticals Ltd. 17 Monate 32 EudraCT-2010-021926-37
2012 Irritable bowel syndrome Laves Arzneimittel 2 Jahre 65
2012 Chronic obstructive pulmonary disease Almirall 5 Monate 27 EudraCT-2011-001524-38
2012 Smoking cessation Pfizer Pharma 2 Jahre 371 EudraCT- 2010-022914-15
2012 Depression Shire Development LLC 12 Monate 44 EudraCT-2011-003018-17
2012 Depression MSD 10 Monate 5 EudraCT-2011-005200-15
2012 Depression H. Lundbeck 8 Monate 19 EudraCT-2012-001380-76
2013 Binge Eating Shire Development LLC 2 Monate 2 Eudra CT-2012-003310-14
2013 Chronic obstructive pulmonary disease Glaxo Smith Kline Research & Development Ltd. 1 Woche 2 EudraCT-2011-001644-29
2013 Constipation Ferring Pharmaceuticals 6 Monate 24 EudraCT-2012-005588-28
2013 Vaccination againt herpes zoster and influenza Glaxo Smith Kline Research & Development Ltd. 1 Monat 16 EudraCT-2015-000965-30
2013 COPD Almirall, Astra Zeneca 3 Monate 20 EudraCT-2013-000116-14
2014 Irritable bowel syndrome Menarini 6 Monate 15 EudraCT-2013-000894-56
2014 Binge Eating Shire Development LLC 1 Monat 1 EudraCT-2012-004457-88
2014 Vaccination against clostridium difficile Sanofi-Pasteur 11 Monate 6 EudraCT-2013-000775-32
2014 COPD Novartis 2 Monate 21 EudraCT-2013-001477-25
2014 COPD Glaxo Smith Kline Research & Development Ltd. 6 Wochen 12 EudraCT-2011-005914-12
2014 COPD Glaxo Smith Kline Research & Development Ltd. 2 Monate 15 EudraCT-2014-000611-14
2015 Depression Alkermes 6 Monate 48 EudraCT-2014-000379-14
2015 COPD Astra Zeneca 4 Monate 11 EudraCT-2014-004715-37
2015 Smoking cessation Philip Morris 1 Monat 28 EudraCT- 2013-002447-29
2015 Fibromyalgia DaiichiSankyo Deutschland 7 Monate 28 EudraCT-2013-005164-26
2015 COPD Pearl 4 Monate 29 EudraCT-2014-004712-10
2016 Influenza Vertex 3 Monate 1 EudraCT- 2014-004068-39
2016 Therapy-resistant depression Janssen-Cilag 10 Monate 3 EudraCT-2014-004587-38
2016 Grass pollen allergy Allergopharma 2 Monate 33 EudraCT- 2015-002409-13
2016 Arthrosis PBB Entrepreneur Ltd. 4 Monate 56
2016 Asthma Astra Zeneca 1 Monat 10 EudraCT- 2004-004042-41
2016 Heartburn Reckitt Benckiser 5 Monate 33 EudraCT-2014-005261-69
2016 Hyperlipidemia Esperion Therapeutics 6 Monate 12 EudraCT-2016-004115-12
2015 Diabetes Mellitus Astra Zeneca 4 Monate 9 EudraCT-2015-002376-24
2016 Neck and back pain Esperion Therapeutics, Boehringer Ingelheim 5 Monate 90 EUdraCT-2015-000404-25
2016 Sleep disorder from the age of 55 Esperion Therapeutics, Astra Zeneca 5 Monate 32 EudraCT-2015-004136-36
2016 Prodrome alzheimer disease Reckitt Benckiser, Boehringer Ingelheim 1 Monat 1 EudraCT-2013-005031-24
2016 Memory disorder Pearl, Boehringer Ingelheim 6 Monate 16 EudraCT-2013-005040-28
2016 Birth control DaiichiSankyo Deutschland, Estetra SPRL 5 Monate 21 EudraCT-2013-005164-26
2016 COPD Astra Zeneca 3 Monate 31 EudraCT-2015-005444-33
2016 Irritable bowel syndrome SymbioPharm 5 Monate 33 EudraCT- 2011-004593-29
2016 Onychomycosis Polichem 5 Monate 60 EudraCT-2015-000561-31
2016 Irritable bowel syndrome Colibiogen 4 Monate 11 EudraCT-2011-001743-78